Aptus Pharma Ltd Financial Ratios
APPL · Consumer Goods · Current price ₹482.1
P/E ratio
179.2x
P/B ratio
24.5x
ROE
19.8%
ROCE
23.5%
Debt / Equity
0.31
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 179.2x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 24.5x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 19.8% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 23.5% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.31 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Aptus Pharma Ltd's latest numbers.
Aptus Pharma Ltd profitability
Aptus Pharma Ltd generates a return on equity of 19.8% and a return on capital employed of 23.5%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.31 and a P/E of 179.2x, Aptus Pharma Ltd is conservatively financed. Our overall business-quality score for the company is 5.7 / 10.
Understand the ratios
More on Aptus Pharma Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.